What is the CanAssist Breast test?

CanAssist Breast is a prognostic test that helps predict the risk of breast cancer recurrence and supports oncologists in personalizing treatment plans.

Who can benefit from the CanAssist Breast test?

It is suitable for patients diagnosed with early-stage, hormone receptor-positive breast cancer to determine their recurrence risk.

How accurate is the CanAssist Breast test?

CanAssist Breast has been validated on South Asian and Caucasian populations, demonstrating high accuracy in predicting recurrence risk.

Clinical Research Validating Breast Cancer Recurrence Risk Tests

Global Entrepreneurship Conference

Events and Conferences

January, 2025

Women in Tech at Global Entrepreneurship Conference

View

Cureus Part of Springer Nature

Scientific Publication by Renowned Oncologists Worldwide

December, 2024

Somashekhar S P et al: Real-World Evidence of the Impact of CanAssist Breast on Physician’s Decision About the Use of Adjuvant Chemotherapy in Early Breast Cancer

View

San Antonio Breast Symposium

Events and Conferences

December, 2024

Real world data on prognostication in India using CanAssist Breast- an indigenous test validated in global studies

View

Breastanbul

Events and Conferences

October, 2024

Dr. Manjiri Bakre was delighted to present real-world data on CanAssist Breast at the Breastanbul 2024, Conference, sharing key insights with global experts

View

Cureus Part of Spinger Nature

Scientific Publication by OncoStem

September, 2024

Comparison of Risk Stratification by CanAssist Breast Test Performed on Core Needle Biopsies Versus Surgical Specimens in Hormone Receptor-Positive, Her2-Negative Early Breast Cancer

View

ESMO Congress

Events and Conferences

September, 2024

Real-world data on prognostication of early-stage breast cancer patients using CanAssist Breast

View

GAPM; Gujarat Association of Pathologists and Microbiologists (GAMP)

Events and Conferences

December, 2023

Talk given by Dr. Manjiri Bakre on 'Does every breast cancer patient need chemotherapy? And Role of “Made in India” innovative tests in decision making to a talented audience of Pathologists and Microbiologists at GAPM 2023, in Vadodara

View

Scientific Publications